论文部分内容阅读
在急性心肌梗塞患者的冠状动脉内注入链激酶,为缺血心肌的重新灌注提供了一个令人鼓舞的和崭新的措施,但对其确切的效益,尚无可靠的评价。与冠状动脉内注入链激酶相比,静脉注入链激酶是一种较少损伤的、经济而较易采用的方法。本文通过8份随机化试验资料进行了综合研究。试验组患者都采用静脉注入
The introduction of streptokinase into the coronary arteries of patients with acute myocardial infarction provides an encouraging and brand new measure of reperfusion of ischemic myocardium, but there is no definitive assessment of their exact benefits. Intravenous streptokinase is a less damaging, economical, and easier-to-use method than injecting streptokinase into the coronary arteries. This article conducted a comprehensive study of eight randomized trials. Patients in the experimental group were given intravenous injection